Loading...
Docoh

Cytek BioSciences (CTKB)

Cytek Biosciences is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with exquisite sensitivity. Cytek’s FSP platform includes its core instruments, the Aurora and Northern Lights systems, its cell sorter, the Aurora CS, and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe.

Company profile

Ticker
CTKB
Exchange
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
Cytek (Shanghai) BioSciences Co., Ltd. • Cytek (Wuxi) BioSciences Co. Ltd. • Cytek (Shanghai) Software Development Technology Co., Ltd. • Cytek Biosciences B.V. • Cytek Japan Corporation ...
IRS number
472547526

CTKB stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
$16.00
Low target
$15.00
High target
$17.00
Morgan Stanley
Maintains
Equal-Weight
$15.00
12 Aug 22
Goldman Sachs
Maintains
Buy
$17.00
11 Aug 22

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

10 Aug 22
16 Aug 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 349.89M 349.89M 349.89M 349.89M 349.89M 349.89M
Cash burn (monthly) 4.2M (no burn) 467K 40.83K (no burn) (no burn)
Cash used (since last report) 6.6M n/a 732.74K 64.07K n/a n/a
Cash remaining 343.3M n/a 349.16M 349.83M n/a n/a
Runway (months of cash) 81.7 n/a 747.7 8567.3 n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
8 Aug 22 Wenbin Jiang Common Stock Sell Dispose S No Yes 15.09 20,000 301.8K 7,841,541
1 Aug 22 Patrick Jeanmonod Common Stock Sell Dispose S No Yes 12.8 3,500 44.8K 94,994
19 Jul 22 Ming Yan Common Stock Sell Dispose S No Yes 11.83 20,000 236.6K 8,064,415
7 Jul 22 Wenbin Jiang Common Stock Sell Dispose S No Yes 11.19 20,000 223.8K 7,861,541
21 Jun 22 Ming Yan Common Stock Sell Dispose S No Yes 10.06 20,000 201.2K 8,084,415
42.6% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 75 53 +41.5%
Opened positions 29 13 +123.1%
Closed positions 7 13 -46.2%
Increased positions 33 20 +65.0%
Reduced positions 9 8 +12.5%
13F shares Current Prev Q Change
Total value 672.61M 730.02M -7.9%
Total shares 57.4M 44.73M +28.3%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Ra Capital Management 13.38M $144.25M +39.3%
3E Bioventures Capital 9.69M $158.09M 0.0%
Hillhouse Capital Advisors 8.76M $94.4M 0.0%
Vanguard 6.35M $68.48M +424.2%
BLK Blackrock 6.09M $65.69M +157.1%
Miura Global Management 2.26M $24.31M -25.3%
STT State Street 1.32M $14.24M +385.5%
Geode Capital Management 921.14K $9.93M +159.4%
D. E. Shaw & Co. 734.06K $7.91M +4534.5%
NTRS Northern Trust 707.46K $7.63M +342.7%
Largest transactions Shares Bought/sold Change
Vanguard 6.35M +5.14M +424.2%
Ra Capital Management 13.38M +3.77M +39.3%
BLK Blackrock 6.09M +3.72M +157.1%
FMR 518.23K -2.15M -80.6%
FIL 583.36K -2.08M -78.1%
Orbimed Advisors 0 -1.92M EXIT
STT State Street 1.32M +1.05M +385.5%
Miura Global Management 2.26M -765K -25.3%
D. E. Shaw & Co. 734.06K +718.22K +4534.5%
Point72 Asset Management 631K +631K NEW

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: begun, EGC, France, fuel, Germany, issuer
Removed: accelerated, anniversary, attest, beneficially, condensed, earliest, nonconvertible